138 related articles for article (PubMed ID: 18991276)
1. Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype.
Hillen N; Mester G; Lemmel C; Weinzierl AO; Müller M; Wernet D; Hennenlotter J; Stenzl A; Rammensee HG; Stevanović S
Eur J Immunol; 2008 Nov; 38(11):2993-3003. PubMed ID: 18991276
[TBL] [Abstract][Full Text] [Related]
2. Wild-type p53 epitope naturally processed and presented by an HLA-B haplotype on human breast carcinoma cells.
Papadopoulos KP; Hesdorffer CS; Suciu-Foca N; Hibshoosh H; Harris PE
Clin Cancer Res; 1999 Aug; 5(8):2089-93. PubMed ID: 10473091
[TBL] [Abstract][Full Text] [Related]
3. Promiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients.
Lasso P; Beltrán L; Guzmán F; Rosas F; Thomas MC; López MC; González JM; Cuéllar A; Puerta CJ
PLoS One; 2016; 11(3):e0150996. PubMed ID: 26974162
[TBL] [Abstract][Full Text] [Related]
4. A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design.
Ebert LM; Liu YC; Clements CS; Robson NC; Jackson HM; Markby JL; Dimopoulos N; Tan BS; Luescher IF; Davis ID; Rossjohn J; Cebon J; Purcell AW; Chen W
Cancer Res; 2009 Feb; 69(3):1046-54. PubMed ID: 19176376
[TBL] [Abstract][Full Text] [Related]
5. T Cell Cross-Reactivity between a Highly Immunogenic EBV Epitope and a Self-Peptide Naturally Presented by HLA-B*18:01+ Cells.
Rist MJ; Hibbert KM; Croft NP; Smith C; Neller MA; Burrows JM; Miles JJ; Purcell AW; Rossjohn J; Gras S; Burrows SR
J Immunol; 2015 May; 194(10):4668-75. PubMed ID: 25855358
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of cross-allele presentation by HLA-A*0301 and HLA-A*1101 revealed by two HIV-derived peptide complexes.
Zhang S; Liu J; Cheng H; Tan S; Qi J; Yan J; Gao GF
Mol Immunol; 2011 Oct; 49(1-2):395-401. PubMed ID: 21943705
[TBL] [Abstract][Full Text] [Related]
7. HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.
Alvarez MG; Postan M; Weatherly DB; Albareda MC; Sidney J; Sette A; Olivera C; Armenti AH; Tarleton RL; Laucella SA
PLoS Negl Trop Dis; 2008; 2(9):e288. PubMed ID: 18846233
[TBL] [Abstract][Full Text] [Related]
8. HLA peptide length preferences control CD8+ T cell responses.
Rist MJ; Theodossis A; Croft NP; Neller MA; Welland A; Chen Z; Sullivan LC; Burrows JM; Miles JJ; Brennan RM; Gras S; Khanna R; Brooks AG; McCluskey J; Purcell AW; Rossjohn J; Burrows SR
J Immunol; 2013 Jul; 191(2):561-71. PubMed ID: 23749632
[TBL] [Abstract][Full Text] [Related]
9. Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
Christensen O; Lupu A; Schmidt S; Condomines M; Belle S; Maier A; Hose D; Neuber B; Moos M; Kleist C; Terness P; Ho AD; Goldschmidt H; Klein B; Hundemer M
J Immunother; 2009; 32(6):613-21. PubMed ID: 19483648
[TBL] [Abstract][Full Text] [Related]
10. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
Berthelot L; Laplaud DA; Pettré S; Ballet C; Michel L; Hillion S; Braudeau C; Connan F; Lefrère F; Wiertlewski S; Guillet JG; Brouard S; Choppin J; Soulillou JP
Eur J Immunol; 2008 Jul; 38(7):1889-99. PubMed ID: 18506883
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype.
Sidney J; Southwood S; Pasquetto V; Sette A
J Immunol; 2003 Dec; 171(11):5964-74. PubMed ID: 14634108
[TBL] [Abstract][Full Text] [Related]
12. Identification of an immunogenic HLA-A*0201-binding T-cell epitope of the transcription factor PAX2.
Asemissen AM; Haase D; Stevanovic S; Bauer S; Busse A; Thiel E; Rammensee HG; Keilholz U; Scheibenbogen C
J Immunother; 2009 May; 32(4):370-5. PubMed ID: 19342968
[TBL] [Abstract][Full Text] [Related]
13. Rapid identification of an HLA-B*1501-restricted vaccinia peptide antigen.
Meyer RG; Graf C; Britten CM; Huber C; Wölfel T
Vaccine; 2007 Jun; 25(24):4715-22. PubMed ID: 17499403
[TBL] [Abstract][Full Text] [Related]
14. Differences in the recognition by CTL of peptides presented by the HLA-B*4402 and the HLA-B*4403 molecules which differ by a single amino acid.
Herman J; Jongeneel V; Kuznetsov D; Coulie PG
Tissue Antigens; 1999 Feb; 53(2):111-21. PubMed ID: 10090611
[TBL] [Abstract][Full Text] [Related]
15. B*2707 differs in peptide specificity from B*2705 and B*2704 as much as from HLA-B27 subtypes not associated to spondyloarthritis.
Gómez P; Montserrat V; Marcilla M; Paradela A; de Castro JA
Eur J Immunol; 2006 Jul; 36(7):1867-81. PubMed ID: 16783853
[TBL] [Abstract][Full Text] [Related]
16. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
Lundberg K; Roos AK; Pavlenko M; Leder C; Wehrum D; Guevara-Patiño J; Andersen RS; Pisa P
Vaccine; 2009 Mar; 27(10):1557-65. PubMed ID: 19171173
[TBL] [Abstract][Full Text] [Related]
17. HLAsupE: an integrated database of HLA supertype-specific epitopes to aid in the development of vaccines with broad coverage of the human population.
Wang S; Guo L; Liu D; Liu W; Wu Y
BMC Immunol; 2016 Jun; 17(1):17. PubMed ID: 27307005
[TBL] [Abstract][Full Text] [Related]
18. Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-specific CTL epitope.
Li Z; Oka Y; Tsuboi A; Fujiki F; Harada Y; Nakajima H; Masuda T; Fukuda Y; Kawakatsu M; Morimoto S; Katagiri T; Tatsumi N; Hosen N; Shirakata T; Nishida S; Kawakami Y; Udaka K; Kawase I; Oji Y; Sugiyama H
Microbiol Immunol; 2008 Nov; 52(11):551-8. PubMed ID: 19090835
[TBL] [Abstract][Full Text] [Related]
19. Identification of a new broad-spectrum CD8+ T cell epitope from over-expressed antigen COX-2 in esophageal carcinoma.
Gao YF; Sun ZQ; Qi F; Qi YM; Zhai MX; Lou HP; Chen LX; Li YX; Wang XY
Cancer Lett; 2009 Oct; 284(1):55-61. PubMed ID: 19423214
[TBL] [Abstract][Full Text] [Related]
20. The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV.
Burrows JM; Wynn KK; Tynan FE; Archbold J; Miles JJ; Bell MJ; Brennan RM; Walker S; McCluskey J; Rossjohn J; Khanna R; Burrows SR
Eur J Immunol; 2007 Apr; 37(4):946-53. PubMed ID: 17357107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
